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ABSTRACT
Japanese cedar pollinosis {JCPsis} is a major national
health problem in Japan. The present review provides
an update on information on JCPsis based on clinical
data from our research group, through the support of
the Department of Health and Welfare {Japanese
Government}, during the period from 1988 to 1997,
because this disease is infrequently documented inter-
nationally despite a large number of publications from
Japan. The information on JCPsis presented here may
be of use in the management of various kinds of polli-
nosis prevalent in other countries. The prevalence rates
of JCPsis vary from district to district and also depend on
the age of the subjects, the method of analysis and the
year of examination in population. Yet, on an average,
the incidence of JCPsis is presumed to be 10-20% in
adults and 5-10% in children. The risk factors for
sensitization and the onset of symptoms seem to be
dependent on the amount of air-borne pollen, the age
of school children, hereditary disposition, including
human leukocyte antigen type and the high levels of
specific IgE in childhood. Because pollen counts also
vary depending on many factors, such as the type of
pollen samplers used, yearly variations, the number of
pollen count stations, the atmospheric temperature and
solar radiation in the previous year of the season,
accurate predictions of daily and seasonal pollen counts
are rather difficult. Commercial crude extracts and
purified allergenic substances Cry i I and II correlate well
with the skin test and the radioallergosorbent test.
Japanese cedar pollen has an allergenic component
that is cross-reactive with Japanese cypress. In many
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patients, the onset of symptoms occurs on the day when
the air-borne pollen count is 10 /cm? {the Durham
method} and, if severe symptoms occur due to intense
exposure to pollen, the symptoms will last for a long time
despite variations in the pollen count {priming effect}.
Eye glasses, face masks and keeping windows and
doors of the house closed are useful measures for pollen
avoidance. Symptom control during the season is not
difficult by the continuous use of new anti-allergic drugs
during the season. If medication is started 1-2 weeks
prior to the onset of the season, more satisfactory results
can be obtained. Specific immunotherapy can not only
control symptoms, but can reduce the amount of
medication and, after completion of the regimen, long-
term remission without medication can be expected.
Key words: Japanese cedar pollinosis, management,
pollen survey, prevalence, risk factor.
INTRODUCTION
In plant taxonomy, cedar trees belong to Cryptomeria D.
Don, Toxadiaceae, Gymnospermae. Based on the analysis
offossil pollens, it is supposed that Toxadiaceae appeared
70 million years ago and were almost completely
destroyed 10-20 million years ago during the glacial
period; only the cedar trees survived the severe conditions
and were distributed in the warm regions around the world.
Natural Japanese cedar trees {Cryptomeria japonica
{JC}; native tree in Japan} are distributed allover Japan,
except in Hokkaido and the Okinawa Islands. However,
many trees were destroyed during the Second World War.
In 1957, the Japanese Government adopted a policy to
plant JC trees on all the barren mountains in Japan in
order to be able to use the timber for building houses and
for preventing flooding due to overflow of rivers. This has
resulted in 349 X 106 m2 of JC forest in the Kanto bloc,
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680 x 106m2 in the Chubu bloc and 523 X 106m2 in
the Kinki bloc and so on in 1982 (Japan is divided into
eight blocs from north to south: Hokkaido, Tohoku,
Kanto, Chubu-Tokai and Hokuriku, Kinki, Chugoku,
Shikoku and Kyushu). When these trees reach the age of
16-35 years, they produce and disperse a large amount
of pollen. Accordingly, air-borne JC pollen (JCP) has
increased since 1965.
In 1964, Horiguchi and Saito et 0/. reported, for the first
time, the existence of patients suffering from Japanese
cedar pollinosis (JCPsis) in Tochigi, Kanto bloc.' Air-borne
JCP has been further increasing with yearly variations and
has finally resulted in a total of 8000 /crn? (pollen count by
Durham's sampler) in 1979 and 1982, leading to a
marked increase in the number of patients with JCPsis.
These facts caused a big sensation in Japan. At present, the
pollen counting system has been established at over 400
points in Japan and pollen forecasts are available in 41 of
47 prefectures in Japan. Since 1988, research groups for
the management of JCPsis have been founded in Japan
through the support of the Department of Health and
Welfare (Japanese Government); Chairmen of these
research groups: S Nishima (1988-90), M Okuda
(1991-95) and T Shida (1996-97).
The purpose of the present review is to produce an
update on the clinical information on JCPsisbased on the
work of our research group,2-9 as this disease is
infrequently documented internationally, despite a large
number of publications from Japan. This information on
JCPsis may also be useful for the management of various
kinds of pollinosis prevalent in other countries.
EPIDEMIOLOGY
Japanese cedar pollen has been shown to be the most
important cause of pollinosis in Japan. Of 353 patients
with pollinosis at the out-patient clinic in Hamamatsu
between 1992 and 1994, the predominant causative
pollen was JCP (68%), followed by Japanese cypress
(38%), orchard grass (23%), ragweed (12%) and
mugwort (10%).6 Air-borne JCP was counted all over
Japan, except for Hokkaido and Okinawa, during the
JCP season (February to April).
Pollen counts varied considerably, depending upon the
districts and the year. Japanese cedar pollen counts were
calculated as the number of pollens deposited on a glass
slide in the Durham's sampler and are expressed as the
number per ern? of slide. The average total number of
JCP from 1989 to 1991 was different from district to
district: 3150 /crn? in the Kanto bloc, 1730 /crn? in the
Kinki bloc, 1580 /crrr' in the Tohoku bloc and 1490 /crn?
in the Chubu block." The sensitization rates of JCP in the
population coincided with the pollen counts in different
districts. Japanese cedar pollen-specific IgE antibody
levels were determined by radioallergosorbent test (RAST)
in randomly selected pooled serum from 1983 to 1984
and the rates of elevated levels of specific IgE antibody in
the sera were 40% in the Kanto bloc, 30% in Tokai, 25%
in Shikoku and 15% in Tohaku and Kyushu blocs."
Another similar study was conducted in 1992 using
pooled serum from a young population of approximately
20 years of age and the rates of positive RAST score (2 or
more) was 21 % in Osaka, Kinki bloc, 16% in Tokyo,
Kanto bloc and Wakayama, Kobe and Nara, Kinki blocs
and 13% in Oita, Kyushu bloc."
The prevalence of pollinosis is on the rise worldwide
and JCPsis is not exceptional. In population studies of
adults in Tochigi, Kanto bloc from 1974 to 1986, the
prevalence rates markedly increased year by year: 3.8%
of 1183 subjects in 1974; 5.8% of 1332 subjects in
1977; 9.8% of 3133 subjects in 1984; and 16.2% of
1862 subjects in 1986.5
Because the prevalence rates of JCPsis are influenced
by many factors, such as other allergic diseases, it is not
easy to present an accurate prevalence rate of JCPsis in
Japan. In 1993, the prevalence rates of JCPsis were
examined by screening, using a telephone enquiry, and
were confirmed by questionnaire or interview in randomly
selected adult subjects. As a result, the prevalence rate of
JCPsis was presumed to be 12.3% of 5530 subjects
examined in the Tokyo district and 10.4% of 3260
subjects in the Osaka district."
The prevalence of JCPsis in school children and in
students was investigated in Shizuoka, Tokai bloc, in
1990 and was presumed to be 7.0% in a total of 50 000
children and students of primary, middle and high
schools." Another similar study was conducted in a total
of 2000 school children and students by questionnaire
and RAST in Tochigi, Kanto bloc, in 1988. As a result,
there was a marked difference in the prevalence rates
between children aged 6 years and less and those who
were older. The prevalence of symptomatic JCPsis was
10% and the prevalence of asymptomatic JCPsis was
21 % in the former group, while in the latter group these
figures were 20 and 40-50, respectively."
There are many reports that pollinosis is prevalent in
urban areas rather than in rural districts."? By comparing
the prevalence rate between rural and urban areas in the
Tokyo district between 1985 and 1989, the rates of
positive RAST to JCP were 27.4% of 873 subjects in the
rural population and 36.5% of 840 subjects in the urban
population; the rotes of symptomatic patients were 12.9
and 19.2%, respectively, although the pollen counts on
an average were higher in rural (6000 /cm2) than in
urban (1250/cm2) districts." Contrary to this result, in an
examination of 159 office workers in an urban district of
Tokyo and 109 in the rural districts of Tokyo in 1990, the
prevalence rates of symptomatic and asymptomatic
subjects were higher in rural than in urban districts (23.9
vs 10.7% in the symptomatic group; 11.9 vs 6.3% in the
asymptomatic qroup]."
Despite these differences in the age of subjects,
districts, the method and year of examination, it was
presumed that the prevalence of JCPsis was 10-20% in
adults and 5-10% in children in Japan.
RISK FACTORS FOR SENSITIZATION AND THE
ONSET OF SYMPTOMS
We studied, as risk factors, the age of subjects, allergen
exposure, hereditary disposition and environmental
conditions.
The age distribution of 1267 patients with JCPsis at our
out-patient clinic was, in order of predominance, 20s, 30s,
teens, below teens, 40s and > 50s. 4 In group exami-
nations of school children by questionnaire and RAST,
drastic increases in the sensitization and/or onset of symp-
toms occurred during the primary school period. 4,5,7 To
determine the predominant factor for the onset of symp-
toms, 34 patients with house dust mite rhinitis, without any
symptoms of JCPsis, were followed for a period of 5 years.
Of these, 10 patients whose RAST scores ranged from 2 to
3 at the onset of the follow-up period and whose age was
in the teens, became symptomatic to JCP'4,6,7
Intensive exposure to JCP may promote sensitization
and may accelerate the onset of symptoms. The rates of
sensitization increased from 39% of 405 subjects in 1994
(180 /crn? pollen count) to 53% of 380 subjects in 1995
(1780/cm 2 pollen count) and symptomatic subjects
increased from 18 to 27%.9
Hereditary disposition is well known as an important
factor for atopic diseases. The analysis of the HLA typing
may be a useful tool for searching atopic disposition. In
both patients with allergy (n = 176) and in controls without
allergy (n = 107), the frequency of the HLA class II allele
was examined using the polymerase chain reaction-
sequence-specific oligonucleotides method, which re-
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vealed that allergic manifestations were significantly
correlated with DQB1*0303 and DPB1*401. Further-
more, the high levels of anti-Cry j 1 IgE antibody also
correlated well with DRB1* 1101, DRB1* 1201, DPB1*501
and DPB1*901 and levels of anti-Cry j II antibody
significantly correlated with DPB1 *401. 4- 7 In a separate
study, there were significant differences in the frequency of
DQB 1*0303 (DQw9) haplotype between JCPsis (52%)
and the control group (20%), but no differences were noted
between JCPsis and mite allergy (69%) or orchard grass
allergy (62%).4-7
Family studies of JCPsis, conducted in 9752 subjects in
Tochigi, Kanto bloc, in 1990 revealed that the prevalence
of JCPsis in children was different, based on the incidence
of atopy in their parents. The incidence of atopy in
children whose parents (both mother and father) were
atopic was 46.7%, significantly greater than that when
the father alone was atopic (25.9%), when the mother
alone was atopic (30.0%) or when neither parent was
atopic (13.7%; control)."
There was no evidence to support the theory that air
pollution, the month of birth, occupation, the keeping of
pets, nutrition and favourite food, or lifestyle cause an
increase in the incidence of JCPsis. 2-A
In conclusion, important risk factors are summarized as
follows: exposure to a large number of JCP over a long
period of time, hereditary disposition, high levels of IgE
antibody to JCP in childhood and a rapid increase in the
level of specific IgE antibody in primary school days.6,8
POLLEN SURVEY
The pollen sampler of Durham's type is commonly used in
Japan to count air-borne pollen for economic reasons. The
relationship between the three types of samplers (Durham's,
rotary and Burkard samplers) in pollen collection were
examined in the same place and on the same day between
1992 and 1996. There was a significant correlation in the
average pollen counts between the Durham's and Rotary
type samplers (correlation coefficient, r = 0.71), between
the Durham's and Burkard samplers (r = 0.58) and
between the Rotary and Burkard type samplers (r = 0.43).
However, the Rotary and Burkard type samplers are more
sensitive than the Durham's sornpler."?
Usually, pollen samplers are set up on roof tops at
levels that are quite high from the ground in order to
avoid disturbance in the sampling from neighboring
buildings. The question arises as to whether or not the
pollen numbers counted on a high roof can truly indicate
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the pollen count inhaled by patients at ground level.
However, there was no difference found in the pollen
count on a roof at a height of 30 m (676 /crrr' count) in
comparison with that on the ground (654 /crrr')."
Total pollen counts vary greatly, year by year. In an
examination in Toyama, Chubu bloc, from 1983 to
1996, pollen counts of less than 1000 /cm? per year
were observed in 1983, 1987, 1989, 1992, 1994 and
1996; counts between 1000 and 4000 were observed in
1984, 1985, 1986, 1988, 1990 and 1997; and counts
of over 4000 were observed in 1991, 1993 and 1995.
The years with high pollen counts occurred at an interval
of 1 or 2 veers."
Total pollen counts in the season also vary greatly, even
in a limited district. At 10 pollen counting points in
Shizuoka, Chubu bloc, in 1991, the total count in the
mountainous areas was 5000 /crn? in Tenryu and 1100
/crn? in Fujinomiya; in the western sea side area it was
2800/cm 2 in Hamamatsu, 2200/cm2 in Iwata, 3000
/cm? in Fujieda and, in the eastern sea side areas, it was
1000/cm2 in Shizuoka, 1800/cm2 in Shimizu, 2000
/cm? in Numazu, 2200 /crn? in Atami and 1900 /crn" in
Shimodc."
Accurate prediction of yearly pollen counts is required
for proper avoidance of pollen by patients and for
appropriate treatment by medical practitioners, as well as
for the proper business management of pharmaceutical
companies. For this purpose, many trials have been
proposed with unsatisfactory results using parameters
such as maximum air temperature or solar radiation in
the previous summer season or the size of male germ in
the autumn of the previous year. From statistical analysis
of total pollen counts over the past 5 years, the following
equation was proposed:"
y = 435.6SL + 592.2FL -8021.6
where y is the predictive pollen in the next year, SL is the
total solar radiation in the previous year's summer and FLis
the sizeof the male germ in the previous year's November.
However, there is no evidence to support that this
formula is applicable to any place in Japan, in any year
and in any weather in the JCP season.
ALLERGEN OF JCP
Japanese cedar pollen is globe shaped with a short
papilla, 30 urn in diameter, that ruptures easily in water,
resulting in the escape of the intragrain plasma to the
outside of the pollen particle.
Two allergenic substances, Cry j I and II, have been
extracted and purified from JCP and their amino acid
sequences have recently been c1arified. 11,12 These
substances are mainly contained in the exine. 13 The
amount of Cry j I in two kinds of commercial crude
extracts for prick test (Torrii, Tokyo, Japan and the
Hollister-Stier, Washington, USA) were determined by
ELISA and were compared with each other. In extracts of
1:20 dilution, the Cry i I content was 11 600 ng/mL (USA
product) and 305.0 ng/mL (Japanese product).
Relationships between the allergenic potency of crude
extract (1: 1000 w/v; Hollister-Stier) and the purified
allergenic substances Cry i I and II (100 ng/mL each)
were examined and were compared by skin test and RAST
in patients with JCPsis. The degree of skin reaction to the
three agents correlated well between the three samples.
The RAST correlation coefficients were 0.962, 0.733 and
0.694 between Cry i I and the crude extract, between Cry
i II and the crude extract and between Cry i I and II,
respectivelvt"
Clinically, it is known that patients with JCPsis react with
Japanese cypress (Hinoki). Then, to examine a cross-
reactivity between JCP and Hinoki, anti-Hinoki IgE
antibody was determined in the serum of patients with
JCPsis by RAST. It was revealed that 60% of patients were
also positive to the Hinoki ollerqen."
Furthermore, an IgE ELISA inhibition test was applied to
detect IgE antibody in the sera of patients with JCPsis
commonly reactive to JCP and Hinoki. As a result,
patients were divided into two groups on the basis of their
reaction to allergens. In one group, the antibody of JCP
was strongly inhibited with the JCP extract only, but not
with the Hinoki extract, and the antibody to Hinoki was
strongly inhibited with the Hinoki extract only, suggesting
that the sera contained two kinds of antibodies specific to
each JCP and Hinoki. In the other group, the antibody to
JCP was strongly inhibited with JCP and Hinoki extracts
and the antibody to Hinoki was also inhibited with both
extracts, indicating that the sera contained a common
antibody to JCP and Hinoki. These results indicate that
JCP and Hinoki have a common allergenic substonce.v''
SYMPTOMATOLOGY
Major symptoms of JCPsis are similar to those of other
pollinosis (i.e. nasal symptoms, such as itching, sneezing,
a watery runny nose and a stuffy nose, and eye symptoms,
such as itching and watery eye). However, asthmatic
symptoms and itching of the skin are infrequent in
comparison with their prevalence in patients with grass or
weed pollinosis.P-?
In statistical studies from past pollen counts in
1990-94 in the Tokyc district, Kanto bloc, the symptoms
of many patients started on the day when the pollen count
was 10 /crn? or on the day when accumulated pollen
counts from 1 January of the same year reached 100
/cm2.7 A similar study was conducted in Kyoto, Kinki bloc,
from an analysis of the past 6 years data and revealed
that pollen counts of 30/cm 2 as the square root of
accumulated pollen counts from 1 January are an
indicator for the first manifestation of symptoms in many
potients.i-"
The severity of symptoms during the season is well
correlated with the pollen count; namely, severe in the
year of large dispersion and mild in the year of small
dispersion. However, the degree of symptoms does not
always correlate with the pollen count on individual days
and in individual patients. When severe symptoms occur
by exposure to a large amount of pollen, these symptoms
persist for a longer time, without any close correlation
with the variation in pollen count." This may be explained
by the fact that if the nasal reactivity is once increased
after exposure to pollen, the resultant pathological
changes may be precipitated, lasting for a longer time
and causing a stronger reaction even when exposed to
considerably lesser amounts of pollen.
In contrast, it is necessary to know the relationship
between daily symptoms and pollen counts for pollen
forecasts. Based on statistical analysis of the past data,
the following equation was proposed:"
y = 1.688 + 0.484x
where y is the daily symptom score and x is the square
root of the pollen count accumulated from the first day of
pollen dispersion. The correlation coefficent between y
and x was 0.95.
An equation was also proposed for the relationship
between the rate of accumulation of patients visiting
hospitals per total patients during the season (y) and the
above-mentioned pollen count (x):6
y = 23.69 + 12.98x; r = 0.902
POLLEN AVOIDANCE
Pollen forecast
A daily pollen forecast is now available almost allover
Japan during the JCPsis season. Based on the statistical
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analysis of the past year's data, the following equation
was proposed:"
y = Wx[Fm + Nx(Ftx + Fwi + Frh + Z)]
where W is the factor for weather, Fm is the factor for the
pattern of pollen dispersion during the season, N is the
interval from the first pollen dispersing day, Ftx is the
factor for maximum air temperature, Fwi is the factor for
wind speed, Frh is the factor for relative humidity and Z is
the mean solar radiation.
However, pollen forecasts are not always reliable (i.e.
the rate of correct daily prediction was only 50% in the
Tokyo district in 1997) because of unreliable weather
forecasts and a limited number of pollen count stations.
In addition, the degree of patient symptoms is not always
well correlated with pollen counts, as has been stated
elsewhere in this orticle." Thus, further study is necessary
to correctly predict the severity of symptoms in patients on
the basis of the pollen forecast.
Eye glasses
It is believed, without any evidence, that eye glasses are
useful in the inhibition of penetration of pollen into the
eyes. To provide factual evidence of this, a model
experiment was made using a phantom model of the
head. Vaseline-coated small glass slides were placed on
the spaces between the upper and lower eye lids of the
phantom. Three phantoms, having usual eye glasses, eye
glasses with side protectors or no glasses were left on the
roof top of the hospital for 24 h on 6, 12 and 13 March
1991 and the pollen deposited on the glass slides was
counted and averaged for 3 days. As a result, there were
significant differences in the amount of pollen attached to
the glass slides between the phantoms having glasses (63
/crn-) or glasses with protectors (62/cm2) and those
without glasses (175 /crn-}, but no difference was
detected between the two types of glasses. Because this
may be a model simulating subjects standing outside,
further experiments were conducted simulating subjects
walking around outside.
Three people were asked to walk around the streets for
3 h on 3 and 4 April 1991 with a bicycle. Each bicycle
carried a phantom, with either eye glasses, eye glasses
with protectors or no glasses, on its handlebar. The pollen
deposited on the glass slides between the upper and
lower lid spaces was counted and averaged. There were
differences in the amount of pollen between the
phantoms with eye glasses (9.8 /cm''}, eye glasses with
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protectors (1.8 /crn") and those without glasses
(29/cm 2).4,6 These results strongly suggest that eye
glasses are useful for protection against the penetration
of pollen into the eyes. However, it is necessary to
determine the precise amount of pollen that can be
prevented from entering the eyes in patients using these
glasses. The conjunctival sacs of 18 non-allergic subjects
were washed with 10 mL saline and the pollen count in
the washings was compared between subjects having eye
glasses and those with no glasses in March 1997.
Contrary to results from the experimental model, there
were no differences between subjects with glasses
(3.4 ± 6.4 pollen count/1 0 mL saline) and those without
glasses (2.0 ± 2.1 pollen count/1 0 mL soline)."
Face masks
Face masks are also believed to be of use for the
prevention of the inhalation of pollen, without any factual
evidence to support this. Therefore, the protective effect
of the three types of face masks against pollen inhalation
was examined in an experimental model. A box for
dispersing pollen, in which the pollen number could be
controlled, was connected to face mask A (for general
anesthesia) and subjects were required to use either one
of the three types of mask (cotton gauze (mask B), wet
gauze (mask C) and a mask for workers in a dusty factory
(mask D)) and inhale pollen grains in the box through
mask A. The amount of pollen in the space of mask A and
in the nostril behind masks B, C or D was counted.
Inhibition rates (pollen count ratio: nostril/mask A) were
calculated. The rates were 58.8, 83.3 and 87.0% for
masks B, C and D, respectively. It was revealed that mask
C was most preferable for inhibition due to its low
inspiratory resistance and its cheaper price."
In addition, 16 kinds of commercially available face
masks were tested for inhibition rates and inspiratory
resistance in an experimental model similar to the
aforementioned experiment. The inhibition rates ranged
from 75 to 99% and the resistances ranged from 3.2 to
7.6 mmH 20 . It was then concluded that the cheaper
simple cotton gauze mask is satisfactory for use in the
prevention of pollen inhclotion.?'?
Keeping windows and doors closed
It is reasonable to think that keeping the windows and
doors of a house closed is a means to avoid pollen.
However, accurate evidence to support this has rarely
been presented. To confirm this effect, vaseline-coated
glass slides were left on the floor of the bedroom, living
room and just outside the house for 1 week in March
1991 and 1996. During the period of the experiment, the
doors and windows of the house were kept closed for as
long as possible. The pollen deposited on the glass slides
was counted. The pollen counts in eight houses were less
than 5 /cm 2 in both 1991 and 1996, while pollen counts
outside the house were 200-300/cm2 in 1991 and
100-600/cm2 in 1996.4 This result indicates that
keeping the doors and windows closed can prevent the
entry of pollen into houses.
MEDICAMENT TREATMENT
Because many different anti-allergic drugs are now
available in Japan, it is not difficult to control JCPsis
symptoms during the season. The treatment method of
preseasonal medication, proposed for the first time in
1986,14 brought satisfactory results for JCPsis. Namely,
medications were started 1-2 weeks before the onset of
the season and continued until the end of the season. The
reason why this method is effective is presumed to be that
after patients have been exposed once to a large amount
of pollen in the season, the sensitivity of their nasal
mucosa to pollen increases due to an increase in the
numbers of effector cells, such as mast cells, lymphocytes
and eosinophils, the sensitivity of the nervous reflex
system and histopathological changes. This increased
sensitivity (primary effect) lasts for a long time and
induces resistance to medication.
This treatment method was investigated using different
kinds of drugs by assessing the change in clinical symptoms
and nasal cytology in a total of 113 patients (the
preseasonal group) and in a total of 116 patients (the mid-
seasonal group used as a control). The drugs used were
tranilast (a per oral mast cell stabilizer in 1992), azelastine
(a new anti-histamine in 1992) and oxatomide (a new anti-
histamine in 1993). The preseasonal group was better
controlled than the mid-seasonal group, postponing the
day of onset of symptoms in the season and by decreasing
the number of monoclonal antibody to eosinophil cationic
protein (EG2)-positive eosinophils, neutrophils and
eosinophil cationic protein (ECP) levels in the nasal
secretion.v? However, the single use of each of these drugs
was not satisfactory in controlling the symptoms in the
season of a large number of air-borne pollens (more than
500 /cm? per day) and the combination of topical steroids
or topical steroid alone instead of single use of the new
anti-histamines promised more satisfactory results in
controlling the symptoms." Topical steroids are known to
be safe and potent for the treatment of allergic rhinitis, but
their modes of action ( re not yet completely understood. To
clarify this, nasal scrapings were collected from nine
patients with JCPsis twice before and after the season in
1993, after the continuous use offluticasone nasal spray, a
topical steroid, and the numbers of eosinophils, mast cells
in scrapings and total histamine and ECP after crushing
and extracting from scrapings were measured. In this
experiment, the total amount of histamine and ECP
indicated the number of mast cells and eosinophils,
respectively. In contrast to the control group, without any
medication, the increase in the number of cells as well as in
the amount of chemical substances was strongly inhibited
in the fluticasone qroup.?
The effect of fluticasone on cytokine release from nasal
epithelial cells was also examined. Epithelial cells were
collected from the nasal surface of patients with JCPsis
and were cultured in collagen-coated wells of culture
plates together with 10~7, 10~6 or 10~5 rnol/L fluticasone.
The release of cytokines, such as interleukin (IL)-6, IL-8,
tumor necrosis factor-a and granulocyte-macrophage
colony stimulating factor, in culture supernatants was
inhibited in a dose-dependent manner in the fluticasone
group compared with the control group without
Huticcsone."
Based on these experiments, the major mode of action
of topical steroids in pollinosis is presumed to be the
inhibition of the migration of effector cells locally and the
inhibition of cytokine release from these cells.
IMMUNOTHERAPY
Immunotherapy (IT) is believed to be beneficial for atopic
diseases, especially pollinosis. However, the clinical
efficacy of IT in the treatment of JCPsis is not yet
satisfactory in Japan compared with mite allergy. This
may be due to a larger amount of air-borne pollen in the
season and a lower potency of the extract used for IT, as
has already been stated elsewhere in this article.
Therefore, IT was conducted in patients with JCPsis using
a more potent extract (Hollister-Stier) and the results were
compared in the season of low and high pollen counts
during the period from 1993 to 1997. Because many
effective anti-allergic drugs are available for the
treatment of JCPsis at present, the effect, specific for IT,
should be evaluated from the point of view of its long-
term remission after completion of the IT regimen.
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Patients with JCPsiswho had completed an IT regimen of
2 to 3 years duration and were free from treatment at our
clinic were followed up in 1997. Although we did not
have a placebo control group, we used as a control a
group of JCPsis patients who were treated with the drug
alone. The parameter for evaluation was total days of
symptoms and uptake of the drug during the season. The
criteria for satisfactory results were defined as follows: the
severity of symptom was classified into three grades
(mild, moderate and severe) according to Okuda's
classification 15 and the satisfactory symptom conditions
were defined as no or mild symptoms in the entire
season; otherwise, moderate or severe symptoms within a
total 1 week period during the season. They were also
defined from total days of medication during the season
as no medication or medication within a total 1 week.
Drugs often prescribed were combinations of topical
steroids and novel non-sedative anti-histamines or per
oral mast cell stabilizers; eye drops (a preparation of new
anti-histamines or topical steroids) were also frequently
used.
In 1993 (the year of a large pollen count), satisfactory
symptom conditions were achieved in 100% of 14
patients in the IT group; although medications were
combined, and in 87% of 79 patients in the drug
treatment (DT) group.
In 1994 (the year of a small pollen count), satisfactory
symptom conditions were achieved in 94.7% of 132
patients in the IT group with combined medication and in
93.5% of 46 patients in the DT group.
In 1995 (the year of a large pollen count), satisfactory
symptom conditions were achieved in 87% of 116 patients
in the IT group and 97% of 134 patients in the DT group.
Although the percentage of satisfactory symptom
conditions were comparable with each other in both
groups, the rate of medication for more than 1 month was
lower in the IT group (17%) than in the DT group (67%).
In 1996 (the year of a small pollen count), satisfactory
symptom conditions were achieved in 92% of 177
patients in the IT group and in 94% of 94 patients in the
DT group and the rate of medication for 1 month more
was 37% in the IT group and 72% in the DT group.
In 1997 (the year of a large pollen count), satisfactory
symptom conditions were achieved in 83.5% of 187
patients in the IT group and in 96.5% of 57 patients in the
DT group and the rate of medication of 1 month more
was 49.7 and 100%, respectively.
These results strongly indicate the symptoms are
satisfactorily controlled in 90% of patients with JCPsis in
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both groups in seasons of large pollen counts as well as
in seasons of low pollen counts. However, there is a
significant difference in the rate of medication for over 1
month between the two groups (i.e. 20-40% in the IT
group and 70-80% in the DT group).7-9 One to 3 years
after completing the IT regimen, the prognosis of 78
patients was examined in 1997 (the year of a large pollen
count) by questionnaire. The response rate to the
questionnaire was 80%. Fifty percent of patients had no
or very mild symptoms and 60.9% did not need to take
drugs in the IT group, compared with 21 .3 and 30.7%,
respectively, in the control DT group. In conclusion, IT,
using a potent extract, has a long-lasting beneficial effect
in decreasing symptoms and medication after cessation
of IT treatment. 7~9
After IT with JCP extract (Hollister-Stier) in 17 patients,
serum IgE and IgG4 antibody levels to Cry i I and Cry i II
were increased, contrary to IT with the Japanese product."
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